<DOC>
	<DOCNO>NCT01541605</DOCNO>
	<brief_summary>This study aim evaluate efficacy safety methylphenidate initial treatment acute mania patient bipolar affective disorder .</brief_summary>
	<brief_title>Methylphenidate Treatment Acute Mania</brief_title>
	<detailed_description>Mania regard autoregulatory mechanism enhance unstable vigilance . There increase evidence psychostimulants increase vigilance may effective treat mania . However , control study lack . This two-arm , randomised , placebo-controlled , double-blind , parallel , multi-centre phase IIIb exploratory study evaluate efficacy safety methylphenidate initial treatment acute mania patient bipolar affective disorder .</detailed_description>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>1 . Inpatients 2 . Written informed consent patient competent consent study participation . 3 . Diagnosis : manic episode accord International Classification Diseases 10th Revision ( ICD10 ) : F30.0 , F30.1 , F31.0 F31.1 4 . Male female least 18 year age 5 . YMRS total score ≥ 20 ≤ 45 point 6 . Body mass index ( BMI ) &gt; 17 7 . Patients must able swallow tablet ( study drug ) . 1 . Any current major psychiatric ICD10 disorder exclusion criterion except follow F90 , F17.1 , F17.2 , F40F59 , F60F69 2 . Contraindications treatment methylphenidate except noted otherwise 3 . Serious nonpsychiatric disease , may interfere objective study safety compliance subject , judge investigator 4 . Oral administration monoaminooxidase ( MAO ) inhibitor within two week , fluoxetine within 6 week antidepressant primarily psychotropic substance except specify within one week study entry . 5 . Stable treatment mood stabiliser include lithium , anticonvulsant ( e.g . valproate , carbamazepine ) antipsychotic ( e.g . risperidone , olanzapine ) benzodiazepines NOT exclusion criterion continue ; however , patient receive 2 substance NOT eligible inclusion 6 . Medical history disorder CNS include tic dyskinesia 7 . Medical history cardiovascular disease , severe hypertension , glaucoma , hyperfunction thyroid 8 . Patients congenital acquire long QT syndrome , familiy history QT prolongation , sudden cardiac death significant inherited cardiac disorder ( e.g . family history hypertrophic cardiomyopathy ) . 9 . History Electroconvulsive therapy within last 3 month 10 . Known alcohol drug addiction abuse , except patient abstinence &gt; 3 month . Patients sporadic abuse cannabis ( product ) exclude study . That even true positive Tetrahydrocannabinol ( THC ) screen urine . 11 . Pregnant nursing woman 12 . Concomitant participation clinical trial participation 30 day prior screen 13 . Prior participation study 14 . Suicidality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>